Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database

Bavry, 2005, What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis, J Am Coll Cardiol, 45, 941, 10.1016/j.jacc.2004.11.064 Pfisterer, 2006, Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents, J Am Coll Cardiol, 48, 2584, 10.1016/j.jacc.2006.10.026 Eisenstein, 2007, Clopidogrel use and long term-term clinical outcomes after drug-eluting stent implantation, JAMA, 297, 159, 10.1001/jama.297.2.joc60179 Spaulding, 2007, A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 989, 10.1056/NEJMoa066633 Stone, 2007, Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents, N Engl J Med, 356, 998, 10.1056/NEJMoa067193 Lagerqvist, 2007, Long-term outcomes with drug-eluting stents versus bare-metal in Sweden, N Engl J Med, 356, 1009, 10.1056/NEJMoa067722 Mauri, 2007, Stent thrombosis in randomized clinical trials of drug eluting stents, N Engl J Med, 356, 1020, 10.1056/NEJMoa067731 Kastrati, 2007, Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 1030, 10.1056/NEJMoa067484 Ellis, 2007, Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3445 patients followed for up to 3 years, J Am Coll Cardiol, 49, 1043, 10.1016/j.jacc.2007.01.015 Marzocchi, 2007, Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry, Circulation, 115, 3181, 10.1161/CIRCULATIONAHA.106.667592 Daemen, 2007, Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH registries), Am J Cardiol, 99, 1027, 10.1016/j.amjcard.2006.11.070 Tu, 2007, Effectiveness and safety of drug-eluting stents in Ontario, N Engl J Med, 357, 1393, 10.1056/NEJMoa071076 Stettler, 2007, Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, 937, 10.1016/S0140-6736(07)61444-5 Iakovou, 2005, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126 Ong, 2005, Late angiographic stent thrombosis (LAST) event with drug-eluting stents, J Am Coll Cardiol, 45, 2088, 10.1016/j.jacc.2005.02.086 Spertus, 2006, Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry, Circulation, 113, 2803, 10.1161/CIRCULATIONAHA.106.618066 Machecourt, 2007, Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and non-diabetic patients, J Am Coll Cardiol, 50, 501, 10.1016/j.jacc.2007.04.051 Airoldi, 2007, Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment, Circulation, 116, 745, 10.1161/CIRCULATIONAHA.106.686048 Beohar, 2007, Outcomes and complications associated with off-label and untested use of drug-eluting stents, JAMA, 297, 1992, 10.1001/jama.297.18.1992 Win, 2007, Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents, JAMA, 297, 2001, 10.1001/jama.297.18.2001 James, 2009, Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden, N Engl J Med, 360, 1933, 10.1056/NEJMoa0809902 Yusuf, 2001, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Steinhubl, 2002, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention, JAMA, 288, 2411, 10.1001/jama.288.19.2411 Bhatt, 2007, Patients with prior myocardial infarction, stroke or symptomatic peripheral arterial disease in the CHARISMA trial, J Am Coll Cardiol, 49, 1982, 10.1016/j.jacc.2007.03.025 Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4 Grines, 2007, Circulation, 115, 813, 10.1161/CIRCULATIONAHA.106.180944 Becker, 2008, The primary and secondary prevention of coronary artery disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 776S, 10.1378/chest.08-0685 Bavery, 2007, Drug-eluting stents: dual antiplatelet therapy for every survivor?, Circulation, 116, 696, 10.1161/CIRCULATIONAHA.107.719484 Mosca, 2005, Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting, Circulation, 111, 488, 10.1161/01.CIR.0000153859.66086.85 Sarawate, 2006, Gout medication treatment patterns and adherence to standards of care from a managed care perspective, Mayo Clin Proc, 81, 925, 10.4065/81.7.925 Arnason, 2006, Accuracy of coding for possible warfarin complications in hospital discharge abstracts, Thromb Res, 118, 253, 10.1016/j.thromres.2005.06.015 Cole, 2004, Adjusted survival curves with inverse probability weights, Comput Methods Programs Biomed, 75, 45, 10.1016/j.cmpb.2003.10.004 Alexander, 2005, Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes, JAMA, 294, 3108, 10.1001/jama.294.24.3108 Nikolsky, 2007, Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach, Eur Heart J, 28, 1936, 10.1093/eurheartj/ehm194 Rao, 2004, Relationship between blood transfusion and clinical outcomes in patients with acute coronary syndromes, JAMA, 292, 1555, 10.1001/jama.292.13.1555 Stone, 2007, Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation, Circulation, 115, 2842, 10.1161/CIRCULATIONAHA.106.687186 Urban, 2006, Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry, Circulation, 113, 1434, 10.1161/CIRCULATIONAHA.104.532242 Ho, 2008, Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome, JAMA, 299, 532, 10.1001/jama.299.5.532